Translational Challenges

Global Health

Our vision is a world with affordable and accessible solutions to better understand, treat, and prevent infectious diseases.

Home » Translational Challenges » Global Health

Infectious diseases disregard national borders. They are some of the biggest threats facing human health. 

Within the umbrella of global health, we have focused on 3 Translational Challenges: antimicrobial resistance, emerging viral threats, and neglected tropical diseases.

We collaborate with experts in this space and use our expertise in translation to help remove barriers and progress promising science.

Translational Challenges within Global Health

Antimicrobial Resistance (AMR)

Partnering to fight drug-resistant infections.

Neglected Tropical Diseases

Supporting the elimination and control of tropical diseases.

Emerging Viral Threats (EVTs)

Tackling established viruses and potential epidemics.

What do we want to achieve?

Focusing our efforts where patient need is greatest and listening to those with lived experiences, we aim to:

  • improve understanding of diseases
  • connect experts across global health research
  • support sustainable capacity growth
  • contribute to making medicines and diagnostics affordable and accessible
  • unblock barriers that keep solutions from reaching patients
Bird-eye view of a group of young business people playing games in a cheerful atmosphere during a break at work. Business, people, company

How you can work with us


We pursue collaborations that:

  • Focus on urgent local needs in low- and middle-income countries
  • Aim to create a more equitable and sustainable global research ecosystem


We invest in projects that:

  • Co-create new research infrastructure
  • Support capacity growth where it’s most needed
  • Remove obstacles in the scientific discovery pathway
  • Create more opportunities for funding

Scientific support

Our team can help you:

  • Translate new therapeutics
  • Develop diagnostics and biomarkers
  • Discover and humanise antibodies
  • Protect your intellectual property

Partnerships and initiatives

Pic Alan Richardson Dundee, Free to Use from the University of St Andrews International Conference on tuberculosis School of Medicine


A £30 million initiative with Innovate UK and Medicines Discovery Catapult, driving new developments to tackle antimicrobial resistance.

iiCON and the Liverpool School of Tropical Medicine

We are partnering with the Liverpool School of Tropical Medicine (LSTM) to launch a new £2.7 million Translational Development Fund. 

The Francis Crick Institute and the Crick Africa Network

We have partnered with the Crick Africa Network (CAN), to provide £7.5 million towards community science programmes.

5 researchers in white lab coats stand together smiling with their arms around each other's shoulders.

Who to contact

Related stories

See our other Translational Challenges

Motor Neuron Disease  

Our vision is a world where motor neuron disease is preventable and treatable. 

Chronic Respiratory Infection 

Our vision is improved quality of life for those living with cystic fibrosis and bronchiectasis. 

Rare Disease

Our vision is an ecosystem working together to get discoveries and treatments to rare disease patients faster. 

Blue chromosome DNA and gradually glowing flicker light matter chemical when camera moving closeup. Medical and Heredity genetic health concept. Technology science. 3D illustration rendering

Childhood Cancer

Our vision is to drive life-changing innovations for children with cancer.

WordPress development by Andy White using PorterWP